Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
National Institutes of Health
Award ceiling
$200,000
Program funding
$200,000
- Opportunity #
- PAR-25-096
- Agency
- National Institutes of Health
- ALN (CFDA)
- 93.393, 93.121, 93.172, 93.866
- Status
- posted
- Posted
- Nov 18, 2024
- Closes
- Nov 17, 2026
- Funding instrument
- Grant
- Category
- Education, Health
- Cost sharing required
- No
Who can apply
- •Independent school districts
- •Native American tribal governments (Federally recognized)
- •Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- •County governments
- •For profit organizations other than small businesses
- •State governments
- •Public and State controlled institutions of higher education
- •Special district governments
- •Others (see text field entitled "Additional Information on Eligibility" for clarification)
- •Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- •Small businesses
- •City or township governments
- •Private institutions of higher education
- •Public housing authorities/Indian housing authorities
- •Native American tribal organizations (other than Federally recognized tribal governments)
Synopsis
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data. Applicants are encouraged to leverage and perform innovative analyses of the existing data. Applications may include new research aims that are being addressed with existing data, new or advanced methods of analyses, or novel combinations and integration of datasets that allow the exploration of important scientific questions in cancer research.
Contact
National Institutes of Health · grantsinfo@nih.gov